Konkurencja i konsument · 27/02/2001
FTC Requests Public Comment on Generic Drug Competition Study
The Federal Trade Commission (FTC) has submitted a study on generic drug competition to the Office of Management and Budget (OMB) for review and clearance, seeking public comment on the proposed information collection requests.
Source: Federal Register — Federal Trade CommissionOpen original release →